Your cart is empty.
Practice Molecular tools - Recombinant DNA technology and Other Tools in Biotechnology - Biotechnology previous year questions organised from real papers, with year-wise coverage and clear topic navigation.
Every graph below is calculated only from this selection.
Year-wise coverage for Molecular tools. Each bar uses a separate theme-derived color.
How the classified questions are distributed by difficulty.
MCQ, numerical, multiple-select and other formats found in these papers.
Top subjects by unique question coverage.
Top topics across the included previous year papers.
Top subtopics inside this exact selection.
Question coverage for the most populated papers. Every active PYP paper remains listed below.
Newest papers appear first. Sort by year, question coverage or name.
| Paper | Year / session | Questions in this view | Open |
|---|---|---|---|
| Biotechnology (BT) 2024 | 2024 | 1 | View paper |
| Biotechnology (BT) 2023 | 2023 | 1 | View paper |
| Biotechnology (BT) 2013 | 2013 | 5 | View paper |
| Biotechnology (BT) 2012 | 2012 | 5 | View paper |
Practice every matching question in batches of 20, with every available option.
The first humanized monoclonal antibody approved for the treatment of breast cancers
Match the entries in Group I with the entries in Group II.
| Group I | Group II |
|---|---|
| P. RNase P | 1. Polyadenylation |
| Q. RNase H | 2. Splicing |
| R. snRNAs | 3. Ribozymes |
| S. CstF | 4. DNA-RNA hybrids |
In hybridoma technology, which one of the following enzymes is absent in the myeloma cells that are used for monoclonal antibody production?
Which one of the following is the basic principle of Sanger’s DNA sequencing method?